ESRF Lightsource Helps Tailoring New Treatments Against Asthma

PRESS RELEASE- Researchers from Sweden and France have deciphered the crystal structure of a human membrane protein which has a major influence on the development of asthma. They used the highly automated ESRF macromolecular crystallography experimental stations (beamlines) to determine the structure of this pharmaceutically important protein, only the third human membrane protein to be solved. The scientists now believe that their work will enable the development of new and better therapeutic drugs targeting inflammation of the respiratory tract.

MORE ON THIS TOPIC